Bhattacharya, Mallar http://orcid.org/0000-0002-5439-547X
Ramachandran, Prakash http://orcid.org/0000-0001-5996-2413
Funding for this research was provided by:
U.S. Department of Defense (W81XWH211417)
RCUK | Medical Research Council (MR/W015919/1)
Article History
Received: 16 April 2023
Accepted: 8 June 2023
First Online: 20 July 2023
Competing interests
: M.B has performed consultancy work for Merck and Ono Pharma. P.R. has received research support from Genentech, Intercept Pharmaceuticals, and NeoGenomics. P.R. has performed consultancy work for Merck.